Cited 17 time in
Enhancement of IGF-2-induced neurite outgrowth by IGF-binding protein-2 and osteoglycin in SH-SY5Y human neuroblastoma cells
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jeong, Eun Young | - |
| dc.contributor.author | Kim, Sujoeng | - |
| dc.contributor.author | Jung, Soonwoong | - |
| dc.contributor.author | Kim, Gyeongwha | - |
| dc.contributor.author | Son, Hyeonwi | - |
| dc.contributor.author | Lee, Dong Hoon | - |
| dc.contributor.author | Roh, Gu Seob | - |
| dc.contributor.author | Kang, Sang Soo | - |
| dc.contributor.author | Cho, Gyeong Jae | - |
| dc.contributor.author | Choi, Wan Sung | - |
| dc.contributor.author | Kim, Hyun Joon | - |
| dc.date.accessioned | 2022-12-27T00:22:33Z | - |
| dc.date.available | 2022-12-27T00:22:33Z | - |
| dc.date.issued | 2013-08 | - |
| dc.identifier.issn | 0304-3940 | - |
| dc.identifier.issn | 1872-7972 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/20529 | - |
| dc.description.abstract | A previous study using a mouse model of depression showed that chronic immobilization stress (CIS) reduces levels of insulin-like growth factor (IGF)-2, IGF binding protein 2 (IGFBP2), osteoglycin, and fibromodulin in the amygdala. Here, using human neuroblastoma cells, we tested whether these four proteins cooperatively modulate neuronal plasticity. We found that IGF-2 and IGFBP2 synergistically increased neurite outgrowth via enhanced early signaling through the IGF type 1 receptor. Furthermore, we found that osteoglycin, a small leucine-rich proteoglycan, significantly increased IGF-2/IGFPB2-induced neurite outgrowth, but fibromodulin had no effect. We also found that central amygdala neurons of CIS-induced depressive mouse showed a decreased total dendritic length. These findings suggest that CIS-responsive proteins modulate neuronal morphology during chronic stress. (C) 2013 Elsevier Ireland Ltd. All rights reserved. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | Enhancement of IGF-2-induced neurite outgrowth by IGF-binding protein-2 and osteoglycin in SH-SY5Y human neuroblastoma cells | - |
| dc.type | Article | - |
| dc.publisher.location | 아일랜드 | - |
| dc.identifier.doi | 10.1016/j.neulet.2013.05.038 | - |
| dc.identifier.scopusid | 2-s2.0-84880177912 | - |
| dc.identifier.wosid | 000322092000047 | - |
| dc.identifier.bibliographicCitation | Neuroscience Letters, v.548, pp 249 - 254 | - |
| dc.citation.title | Neuroscience Letters | - |
| dc.citation.volume | 548 | - |
| dc.citation.startPage | 249 | - |
| dc.citation.endPage | 254 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Neurosciences & Neurology | - |
| dc.relation.journalWebOfScienceCategory | Neurosciences | - |
| dc.subject.keywordPlus | GROWTH-FACTOR-BINDING | - |
| dc.subject.keywordPlus | LEUCINE-RICH PROTEOGLYCANS | - |
| dc.subject.keywordPlus | EXTRACELLULAR-MATRIX | - |
| dc.subject.keywordPlus | GENE-EXPRESSION | - |
| dc.subject.keywordPlus | FACTOR-II | - |
| dc.subject.keywordPlus | INSULIN | - |
| dc.subject.keywordPlus | NEURONS | - |
| dc.subject.keywordAuthor | IGF-2 | - |
| dc.subject.keywordAuthor | IGFBP2 | - |
| dc.subject.keywordAuthor | Osteoglycin | - |
| dc.subject.keywordAuthor | Neurite outgrowth | - |
| dc.subject.keywordAuthor | SH-SY5Y | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
